NCT00002592View on ClinicalTrials.gov

Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 1993

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Leukemia
Interventions
BIOLOGICAL

c-myb antisense oligonucleotide G4460

BIOLOGICAL

filgrastim

DRUG

busulfan

DRUG

cyclophosphamide

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

in vitro-treated bone marrow transplantation

Trial Locations (1)

19104-4283

University of Pennsylvania Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER